Report Thumbnail
Product Code LP0913912527U9
Published Date 2026/3/25
English104 PagesGlobal

Global Thbrthdrexvbdr Market Growth 2026-2032 ‐ Materials / Chemicals Market


Report Thumbnail
Product Code LP0913912527U9◆An updated version may be available. We will check for you.
Published Date 2026/3/25
English 104 PagesGlobal

Global Thbrthdrexvbdr Market Growth 2026-2032 ‐ Materials / Chemicals Market



Abstract

This report provides a comprehensive analysis of the global calcium pantothenate (Vitamin B5) market, projecting growth trajectories from 2025 through 2032. Driven by increasing health awareness and aging populations, the market is segmented by type, including chemical synthesis and biodegradation, and across pharmaceutical, food, agricultural, and cosmetic applications. The study evaluates regional dynamics, particularly the significant role of Chinese exports to Europe, Asia, and North America, while profiling key industry players and competitive strategies.

Related Questions

Shanghai Pharmaceutical Industry Corporation Limited, Yifan Pharmaceutical Co.,Ltd., Xinfa Pharmaceutical, Shandong Huachen Pharmaceutical Co., Ltd., Brother Enterprises Holding Co.,Ltd., DSM, BASF, Hubei Mackas Refined Chemical Technology Co., Ltd., Hunan Jingchang Biological Products Co., Ltd., Wuhan Xingshengjie Technology Co., Ltd.


Summary

Market Overview

The global Thbrthdrexvbdr market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Product Definition

Calcium D-pantothenate, chemically identified as N-(α,γ-dihydroxy-β,β-dimethylbutyryl)-β-alanine calcium and commonly known as vitamin B5, serves as a vital component of coenzyme A.

Market Dynamics and Regional Insights

Growth Drivers

The market prospects for calcium pantothenate are exceptionally broad, driven by:

  • The ongoing development of society and the economy.
  • Improving global health awareness among the population.
  • The intensification of global aging trends.

China Market Analysis

Due to overcapacity within the domestic vitamin industry, export serves as the primary demand driver for the Chinese market.

  • Market Size (China): The Chinese calcium pantothenate industry reached 7.27 billion yuan in 2022 and is expected to exceed 8 billion yuan in 2023.
  • Export Performance (2022):
  • Export Volume: 11,800 tons (representing a year-on-year decrease of 38.49%).
  • Export Value: 255 million yuan (representing a year-on-year increase of 37.84%).
  • Price Trends: Prices have risen significantly due to supply and demand dynamics.
  • Export Distribution (2022):
  • Major Regions: Europe, Asia, and North America accounted for 87.3% of total exports.
  • Key Exporting Countries: The United States and Belgium are the primary exporters for China.
  • Market Share by Country:
  • United States: 21.7%
  • Belgium: 18.1%
  • Netherlands: 9.2%
  • Germany: 6.1%
  • Brazil: (Market presence noted)

Report Scope and Methodology

This research report by LP Information, Inc. (LPI), titled “Thbrthdrexvbdr Industry Forecast,” provides a comprehensive analysis of the global Thbrthdrexvbdr landscape. It reviews total world sales for 2025 and provides detailed projections for 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

Analytical Focus

The report highlights key trends including:

  • Product segmentation and company formation.
  • Revenue and market share analysis.
  • Latest developments and M&A activity.
  • Leading global company strategies, focusing on portfolios, capabilities, market entry strategies, market positions, and geographic footprints.

This study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the market, identifying emerging pockets of opportunity.

Market Segmentation

By Type

  • Chemical Synthesis
  • Biodegradation

By Application

  • Agricultural Field
  • Pharmaceutical Industry
  • Food Industry
  • Cosmetic Raw Materials

By Geography

  • Americas: United States, Canada, Mexico, Brazil
  • APAC: China, Japan, Korea, Southeast Asia, India, Australia
  • Europe: Germany, France, UK, Italy, Russia
  • Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolios, and market penetration:

  • Shanghai Pharmaceutical Industry Corporation Limited
  • Yifan Pharmaceutical Co.,Ltd.
  • Xinfa Pharmaceutical
  • Shandong Huachen Pharmaceutical Co., Ltd.
  • Brother Enterprises Holding Co.,Ltd.
  • DSM
  • BASF
  • Hubei Mackas Refined Chemical Technology Co., Ltd.
  • Hunan Jingchang Biological Products Co., Ltd.
  • Wuhan Xingshengjie Technology Co., Ltd.

Key Questions Addressed

  • What is the 10-year outlook for the global Thbrthdrexvbdr market?
  • What factors are driving Thbrthdrexvbdr market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Thbrthdrexvbdr market opportunities vary by end market size?
  • How does Thbrthdrexvbdr break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Thbrthdrexvbdr Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Thbrthdrexvbdr by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Thbrthdrexvbdr by Country/Region, 2021, 2025 & 2032
    • 2.2 Thbrthdrexvbdr Segment by Type
      • 2.2.1 Chemical Synthesis
      • 2.2.2 Biodegradation
      • 2.2.3 Thbrthdrexvbdr Sales by Type
        • 2.2.3.1 Global Thbrthdrexvbdr Sales Market Share by Type (2021-2026)
        • 2.2.3.2 Global Thbrthdrexvbdr Revenue and Market Share by Type (2021-2026)
        • 2.2.3.3 Global Thbrthdrexvbdr Sale Price by Type (2021-2026)
    • 2.3 Thbrthdrexvbdr Segment by Application
      • 2.3.1 Agricultural Field
      • 2.3.2 Pharmaceutical Industry
      • 2.3.3 Food Industry
      • 2.3.4 Cosmetic Raw Materials
      • 2.3.5 Thbrthdrexvbdr Sales by Application
        • 2.3.5.1 Global Thbrthdrexvbdr Sale Market Share by Application (2021-2026)
        • 2.3.5.2 Global Thbrthdrexvbdr Revenue and Market Share by Application (2021-2026)
        • 2.3.5.3 Global Thbrthdrexvbdr Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Thbrthdrexvbdr Breakdown Data by Company
      • 3.1.1 Global Thbrthdrexvbdr Annual Sales by Company (2021-2026)
      • 3.1.2 Global Thbrthdrexvbdr Sales Market Share by Company (2021-2026)
    • 3.2 Global Thbrthdrexvbdr Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Thbrthdrexvbdr Revenue by Company (2021-2026)
      • 3.2.2 Global Thbrthdrexvbdr Revenue Market Share by Company (2021-2026)
    • 3.3 Global Thbrthdrexvbdr Sale Price by Company
    • 3.4 Key Manufacturers Thbrthdrexvbdr Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Thbrthdrexvbdr Product Location Distribution
      • 3.4.2 Players Thbrthdrexvbdr Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Thbrthdrexvbdr by Geographic Region

    • 4.1 World Historic Thbrthdrexvbdr Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Thbrthdrexvbdr Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Thbrthdrexvbdr Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Thbrthdrexvbdr Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Thbrthdrexvbdr Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Thbrthdrexvbdr Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Thbrthdrexvbdr Sales Growth
    • 4.4 APAC Thbrthdrexvbdr Sales Growth
    • 4.5 Europe Thbrthdrexvbdr Sales Growth
    • 4.6 Middle East & Africa Thbrthdrexvbdr Sales Growth
  • 5 Americas

    • 5.1 Americas Thbrthdrexvbdr Sales by Country
      • 5.1.1 Americas Thbrthdrexvbdr Sales by Country (2021-2026)
      • 5.1.2 Americas Thbrthdrexvbdr Revenue by Country (2021-2026)
    • 5.2 Americas Thbrthdrexvbdr Sales by Type (2021-2026)
    • 5.3 Americas Thbrthdrexvbdr Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Thbrthdrexvbdr Sales by Region
      • 6.1.1 APAC Thbrthdrexvbdr Sales by Region (2021-2026)
      • 6.1.2 APAC Thbrthdrexvbdr Revenue by Region (2021-2026)
    • 6.2 APAC Thbrthdrexvbdr Sales by Type (2021-2026)
    • 6.3 APAC Thbrthdrexvbdr Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Thbrthdrexvbdr by Country
      • 7.1.1 Europe Thbrthdrexvbdr Sales by Country (2021-2026)
      • 7.1.2 Europe Thbrthdrexvbdr Revenue by Country (2021-2026)
    • 7.2 Europe Thbrthdrexvbdr Sales by Type (2021-2026)
    • 7.3 Europe Thbrthdrexvbdr Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Thbrthdrexvbdr by Country
      • 8.1.1 Middle East & Africa Thbrthdrexvbdr Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Thbrthdrexvbdr Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Thbrthdrexvbdr Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Thbrthdrexvbdr Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Thbrthdrexvbdr
    • 10.3 Manufacturing Process Analysis of Thbrthdrexvbdr
    • 10.4 Industry Chain Structure of Thbrthdrexvbdr
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Thbrthdrexvbdr Distributors
    • 11.3 Thbrthdrexvbdr Customer
  • 12 World Forecast Review for Thbrthdrexvbdr by Geographic Region

    • 12.1 Global Thbrthdrexvbdr Market Size Forecast by Region
      • 12.1.1 Global Thbrthdrexvbdr Forecast by Region (2027-2032)
      • 12.1.2 Global Thbrthdrexvbdr Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Thbrthdrexvbdr Forecast by Type (2027-2032)
    • 12.7 Global Thbrthdrexvbdr Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Shanghai Pharmaceutical Industry Corporation Limited
      • 13.1.1 Shanghai Pharmaceutical Industry Corporation Limited Company Information
      • 13.1.2 Shanghai Pharmaceutical Industry Corporation Limited Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.1.3 Shanghai Pharmaceutical Industry Corporation Limited Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Shanghai Pharmaceutical Industry Corporation Limited Main Business Overview
      • 13.1.5 Shanghai Pharmaceutical Industry Corporation Limited Latest Developments
    • 13.2 Yifan Pharmaceutical Co.,Ltd.
      • 13.2.1 Yifan Pharmaceutical Co.,Ltd. Company Information
      • 13.2.2 Yifan Pharmaceutical Co.,Ltd. Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.2.3 Yifan Pharmaceutical Co.,Ltd. Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Yifan Pharmaceutical Co.,Ltd. Main Business Overview
      • 13.2.5 Yifan Pharmaceutical Co.,Ltd. Latest Developments
    • 13.3 Xinfa Pharmaceutical
      • 13.3.1 Xinfa Pharmaceutical Company Information
      • 13.3.2 Xinfa Pharmaceutical Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.3.3 Xinfa Pharmaceutical Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Xinfa Pharmaceutical Main Business Overview
      • 13.3.5 Xinfa Pharmaceutical Latest Developments
    • 13.4 Shandong Huachen Pharmaceutical Co., Ltd.
      • 13.4.1 Shandong Huachen Pharmaceutical Co., Ltd. Company Information
      • 13.4.2 Shandong Huachen Pharmaceutical Co., Ltd. Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.4.3 Shandong Huachen Pharmaceutical Co., Ltd. Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Shandong Huachen Pharmaceutical Co., Ltd. Main Business Overview
      • 13.4.5 Shandong Huachen Pharmaceutical Co., Ltd. Latest Developments
    • 13.5 Brother Enterprises Holding Co.,Ltd.
      • 13.5.1 Brother Enterprises Holding Co.,Ltd. Company Information
      • 13.5.2 Brother Enterprises Holding Co.,Ltd. Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.5.3 Brother Enterprises Holding Co.,Ltd. Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Brother Enterprises Holding Co.,Ltd. Main Business Overview
      • 13.5.5 Brother Enterprises Holding Co.,Ltd. Latest Developments
    • 13.6 DSM
      • 13.6.1 DSM Company Information
      • 13.6.2 DSM Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.6.3 DSM Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 DSM Main Business Overview
      • 13.6.5 DSM Latest Developments
    • 13.7 BASF
      • 13.7.1 BASF Company Information
      • 13.7.2 BASF Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.7.3 BASF Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 BASF Main Business Overview
      • 13.7.5 BASF Latest Developments
    • 13.8 Hubei Mackas Refined Chemical Technology Co., Ltd.
      • 13.8.1 Hubei Mackas Refined Chemical Technology Co., Ltd. Company Information
      • 13.8.2 Hubei Mackas Refined Chemical Technology Co., Ltd. Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.8.3 Hubei Mackas Refined Chemical Technology Co., Ltd. Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 Hubei Mackas Refined Chemical Technology Co., Ltd. Main Business Overview
      • 13.8.5 Hubei Mackas Refined Chemical Technology Co., Ltd. Latest Developments
    • 13.9 Hunan Jingchang Biological Products Co., Ltd.
      • 13.9.1 Hunan Jingchang Biological Products Co., Ltd. Company Information
      • 13.9.2 Hunan Jingchang Biological Products Co., Ltd. Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.9.3 Hunan Jingchang Biological Products Co., Ltd. Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 Hunan Jingchang Biological Products Co., Ltd. Main Business Overview
      • 13.9.5 Hunan Jingchang Biological Products Co., Ltd. Latest Developments
    • 13.10 Wuhan Xingshengjie Technology Co., Ltd.
      • 13.10.1 Wuhan Xingshengjie Technology Co., Ltd. Company Information
      • 13.10.2 Wuhan Xingshengjie Technology Co., Ltd. Thbrthdrexvbdr Product Portfolios and Specifications
      • 13.10.3 Wuhan Xingshengjie Technology Co., Ltd. Thbrthdrexvbdr Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.10.4 Wuhan Xingshengjie Technology Co., Ltd. Main Business Overview
      • 13.10.5 Wuhan Xingshengjie Technology Co., Ltd. Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.